SCHEMBL29654166

SCHEMBL29654166

N#Cc1c(Cl)nc2c(F)c(Cl)ncc2c1N1CCN(C(=O)O)CC1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 5/20 0.33
▸ PDE9A O76083 2/20 0.33
▸ PARP1 P09874 3/20 0.33
▸ CYP2C19 P33261 2/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP3A5 P20815 1/20 0.32
▸ CYP3A7 P24462 1/20 0.32
▸ CYP3A43 Q9HB55 1/20 0.32
▸ RIPK1 Q13546 1/20 0.32
▸ PARP2 Q9UGN5 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25385694 1.00 KRAS (0.33) KRASPDE9APARP1CYP2C19CYP3A4
SCHEMBL24425142 0.85 KCNH2 (0.45) —
SCHEMBL29654280 0.82 KRAS (0.37) KRASCYP2C19CYP3A4CYP2D6CYP3A5
SCHEMBL18128501 0.82 KRAS (0.37) KRASCYP2C19CYP3A4CYP2D6CYP3A5
SCHEMBL25329782 0.81 PDE9A (0.31) PDE9A
SCHEMBL26932692 0.77 ABL1 (0.41) KRASKDM4EALDH1A1NPSR1
SCHEMBL30260098 0.76 KRAS (0.38) KRAS
SCHEMBL25331131 0.74 — —
SCHEMBL25382988 0.73 KRAS (0.36) KRASCYP2C19CYP3A4CYP2D6CYP3A5
SCHEMBL25384534 0.72 KRAS (0.37) KRASCYP2C19CYP3A4CYP2D6CYP3A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022095960-A1 KRAS INHIBITORS FOR TREATMENT OF CANCERS 泰励生物科技(上海)有限公司 2022-05-12 — — WO disclosed
Send feedback